The World Drug Safety Congress Europe will bring together drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches and discuss how you can tackle the challenges of social media and drug safety legislation globally at the World Drug Safety Congress.

The congress is set to bridge the gap between international regulatory bodies, industry professionals and academic representatives and will address how to drive pharmacovigilance operations forward.